Browse Tag

covid 19 vaccine

Latest data on immune response to COVID-19 reinforces need for vaccination

5 mins read

The FINANCIAL --  A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.…

Pfizer and BioNTech to Provide 500 million doses of COVID-19 vaccine to U.S. Government fir Donation to Poorest Nations

8 mins read

The FINANCIAL -- Pfizer Inc. and BioNTech SE announced plans to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200 million doses in 2021 and 300 million doses in the first half of 2022, to further support the multilateral efforts to address the surge of infection in…

How has COVID-19 Changed ‘Superstar Cities’?

6 mins read

The FINANCIAL -- Just over a year since the pandemic led to shut-downs and stay-at-home orders across the world, the rollout of vaccines and gradual reopening of long-shuttered parts of the economy have many wondering when life will return to a pre-pandemic normal, University of Pennsylvania notes.  But amidst the numerous changes this past year…

Health and consumer crisis: Europeans remain cautious

7 mins read

The FINANCIAL -- According to BNP Paribas, for nine months now, Europe has been dealing with the Covid 19 crisis and the resulting restrictions (lockdowns, curfews, etc.) it has imposed. The second wave had not yet hit, but households were already showing very cautious confidence. A far cry from actual optimism on a way out of…

2 in 3 Americans and 3 in 4 Britons are happy to receive coronavirus vaccine

5 mins read

The FINANCIAL — After a vaccine presenting as 90% effective in stage three clinical trials was announced by Pfizer on Monday, 76% of Britons and 66% of Americans say they would be happy to be vaccinated against COVID-19. This likelihood to be vaccinated is supported by the degree of confidence in the vaccination for being…

EU gives green light to Johnson & Johnson to supply 200M doses of COVID-19 vaccine candidate

3 mins read

The FINANCIAL — Johnson & Johnson (NYSE: JNJ) (the Company) today announced the European Commission (EC), acting on behalf of the European Union (EU) Member States, has approved an Advance Purchase Agreement in which the Janssen Pharmaceutical Companies will supply 200 million doses of its COVID-19 vaccine candidate to EU Member States following approval or…